文献速递肝病

细菌感染影响代偿期肝硬化失代偿与生存风险

Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis.
PubMed 文献 · J Hepatol · 2021-04-24

本研究嵌套于PREDESCI试验,纳入201例代偿期肝硬化且肝静脉压力梯度≥10 mmHg的患者,中位随访36个月。17%发生细菌感染,感染组失代偿风险(SHR 2.93)和死亡风险(SHR 6.93)显著增高,腹水风险亦增加(SHR 3.55)。

要点

  • 代偿期肝硬化患者细菌感染发生率为17%,与腹水发生率相近。
  • 细菌感染显著增加失代偿风险,尤其是腹水风险。
  • 细菌感染增加死亡风险,但多数死亡发生在失代偿之后。

核心结论

  • 细菌感染显著增加代偿期肝硬化患者失代偿(主要为腹水)和死亡风险。

研究设计与样本

  • 嵌套于PREDESCI随机对照试验的前瞻性队列研究,纳入201例代偿期肝硬化且肝静脉压力梯度≥10 mmHg的患者,中位随访36个月。

主要发现

  • 34例(17%)发生细菌感染,其中33例感染发生在失代偿之前。
  • 感染组失代偿发生率为26%,非感染组为16%。
  • 细菌感染与失代偿风险升高相关(SHR 2.93;95%CI 1.02-8.42;p=0.047)。
  • 细菌感染与腹水风险升高相关(SHR 3.55;95%CI 1.21-10.47;p=0.022)。
  • 细菌感染与死亡风险升高相关(SHR 6.93;95%CI 2.64-18.18;p<0.001),71%的死亡发生在失代偿后。

临床怎么用

  • 对代偿期肝硬化患者应关注细菌感染的预防和早期识别,可能有助于降低失代偿和死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The prognosis of compensated cirrhosis is good until decompensation. In decompensated cirrhosis, bacterial infections (BIs) are common and increase the risk of death. The incidence and prognostic implications of BIs in compensated cirrhosis are less-well characterized. This study aimed to assess whether BIs influence the risk of decompensation and survival in patients with compensated cirrhosis. METHODS: This is a cohort study nested to the PREDESCI study, a double-blind, multicenter, randomized controlled trial designed to assess whether β-blockers could prevent decompensation of cirrhosis. Patients with compensated cirrhosis and hepatic venous pressure gradient ≥10 mmHg were included. Development of BIs during follow-up was prospectively registered. Using a competing-risk time-dependent regression analysis, we investigated whether BIs affect the risk of decompensation and survival. Decompensation was defined as development of ascites, bleeding or overt encephalopathy. RESULTS: A total of 201 patients were randomized and followed for a median of 36 months (IQR 24-47 months); 34 patients (17%) developed BIs, which occurred before decompensation in 33 cases, and 29 (14%) developed ascites. Respiratory and urinary tract infections were the most frequent BIs. Decompensation occurred in 26% patients with BIs vs. 16% without BIs. Patients with BIs were at higher risk of decompensation (subdistribution hazard ratio [SHR] 2.93; 95% CI 1.02-8.42; p = 0.047) and of developing ascites (SHR 3.55; 95% CI 1.21-10.47; p = 0.022) than those without BIs. Risk of death was also higher in patients with BIs (subdistribution HR 6.93; 95% CI 2.64-18.18; p <0.001), although decompensation occurred before death in 71% of such cases. CONCLUSIONS: BIs have a marked impact on the natural history of compensated cirrhosis, significantly increasing the risk of decompensation, mainly that of ascites, and increasing the risk of death, which usually occurs after decompensation. Our results suggest that BIs may constitute a target to prevent decompensation. LAY SUMMARY: It is widely known that bacterial infections are common and increase the mortality risk in patients with decompensated cirrhosis. However, the relevance of bacterial infections in compensated cirrhosis has not been well studied. This study shows that in patients with compensated cirrhosis and clinically significant portal hypertension, bacterial infections occur as frequently as the development of ascites, which is the most frequent decompensating event. Bacterial infections increase the risk of progression to decompensation, mainly by increasing the risk of ascites, and also increase the risk of death, which usually occurs after decompensation. CLINICALTRIALS. GOV IDENTIFIER: NCT01059396.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Villanueva C, Albillos A, Genescà J, et al. Bacterial infections adversely influence the risk of decompensation and survival in compensated cirrhosis. J Hepatol. 2021. PMID: 33905794. doi:10.1016/j.jhep.2021.04.022

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。